EGA
AMPE

Eagle Global Advisors’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Eagle Global Advisors’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-58
Closed -$61K – 404
2015
Q4 		$61K Sell
58
-15
-21% -$14.8K ﹤0.01% 360
2015
Q3 		$64K Sell
73
-171
-70% -$143K ﹤0.01% 357
2015
Q2 		$173K Buy
+244
New +$260K ﹤0.01% 349

Other funds holding AMPE

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
NFG
Noven Financial Group Denver, Colorado $123M AUM 5.23% 1-Year Est. Return
CK
Carnick & Kubik Colorado Springs, Colorado $334M AUM 1.52% 1-Year Est. Return
FPCP
Fort Point Capital Partners San Francisco, California $825M AUM 16.14% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CP
Camelot Portfolios Maumee, Ohio $143M AUM 14.82% 1-Year Est. Return

Eagle Global Advisors's AMPE Position: Q1 2016 in Review

Eagle Global Advisors sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q1 2016, closing a stake of 58 shares — an estimated $61K sold.

Eagle Global Advisors first reported a position in AMPE in Q2 2015 and held it in 3 quarters. The position peaked at $173K in Q2 2015. 57 funds tracked by Wall St. Rank hold AMPE as of Q1 2016.

  • Eagle Global Advisors reported no remaining Ampio Pharmaceuticals Inc. position as of Q1 2016 after selling out during the quarter.
  • Eagle Global Advisors sold 58 Ampio Pharmaceuticals Inc. shares in Q1 2016, an estimated $61K.
  • Eagle Global Advisors first reported a position in Ampio Pharmaceuticals Inc. in Q2 2015 and held it in 3 quarters.
  • Eagle Global Advisors's Ampio Pharmaceuticals Inc. position peaked at $173K in Q2 2015.
  • 57 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q1 2016.

Based on Eagle Global Advisors's 13F filing for Q1 2016, filed 16 May 2016.